| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP Finance &Operations | VP Finance &Operations
1 company
Carr Douglas is a SVP Finance &Operations at Century Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | IPSC Century Therapeutics, Inc. | SVP Finance &Operations | Sell | 289 | $1.83 | $528.00 | - | -32.3% | -70.0% | |
| May 3, 2024 | IPSC Century Therapeutics, Inc. | SVP Finance &Operations | Sell | 257 | $3.11 | $798.24 | - | -31.0% | -81.8% | |
| Feb 6, 2024 | IPSC Century Therapeutics, Inc. | SVP Finance &Operations | Sell | 1,200 | $4.14 | $4,969.02 | -0.2% | -30.3% | -82.5% |